Clinical trial Recruiting at 14 sites Interventional Ages Any age to 32 Weeks

Improving Kangaroo Care to Prevent Infections in High-risk Infants in NICUs

Official title: Optimising Kangaroo Care to Reduce Neonatal Severe Infection/Sepsis and Resistant Bacterial Colonisation Among High-risk Infants in Neonatal Intensive Care: a Pragmatic, Multicentre, Parallel Cluster Randomised Hybrid Implementation-effectiveness Study.

Run by PENTA Foundation · NCT05993442 · Data updated 2026-11-12

This study is testing whether improved Kangaroo Care can help prevent infections in high-risk infants in neonatal intensive care units.

More Infection, Bacterial trials

Quick facts

Study typeInterventional
AgesAny age to 32 Weeks
SexAll
Enrollment3080 (estimated)
SponsorPENTA Foundation
Research network
Locations24 sites (Athens and 23 other locations)
StatusRecruiting
StartedMay 28, 2024
Main results expectedApril 2026
Study endsMay 2026
Registry record updatedMarch 25, 2026
Trial IDNCT05993442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are high-risk infants admitted to neonatal intensive care units, particularly those born extremely premature.

Probably not a fit

Patients who are not admitted to participating NICUs or those who do not meet the criteria for high-risk infants may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The NeoDeco trial is a multicenter, cluster-randomized study conducted across 24 neonatal units in five European countries. It aims to implement optimized Kangaroo Care (KC) to reduce severe infections and resistant bacterial colonization among high-risk infants in neonatal intensive care units (NICUs). The study involves a baseline assessment, a wash-in period for training, and a 10-month intervention period where KC will be continuously applied. Data on clinical outcomes and bacterial colonization will be collected from all eligible infants during the study.

Why it matters

Potential benefit: If successful, this study could significantly reduce the incidence of severe infections and improve health outcomes for high-risk infants in NICUs.

How similar studies have gone: Previous studies have shown promising results with similar approaches to Kangaroo Care, indicating potential for success in this novel implementation.

Who can join: the full rules

Show full inclusion / exclusion criteria
INCLUSION CRITERIA

1\. Site level

1a. Neonatal unit that provide routinely cares for extremely premature infants (\<28 weeks' gestation).

1b. Minimum capacity of 12 beds.

1c. Access to a -70 to -80°C freezer for storage of research samples

1d. Willing to implement optimised KC if allocated to the intervention group.

1e. Willing to commit to offering the minimum expected target duration or an increase of 50% if neonatal unit is already offering \>67% of the minimum expected target duration, if allocated to the intervention arm.

1f. Prepared to implement NeoIPC surveillance.

1. g. Adequate resources and expertise and approvals from relevant Research Ethics Committees, as appropriate.
2. Infant level

2a. All high-risk infants (born at \<32 weeks' gestation) admitted to participating neonatal units, regardless of complexity of care, anticipated hospitalisation duration, room type, or whether admitted directly after birth.

EXCLUSION CRITERIA 1 Site level

1. a. Participation in other research that could directly influence the study intervention or outcomes.
2. a. Average StSC duration already exceeding 18 hours per day.
3. a. Anticipated major changes in resistant bacterial colonisation pressure during the study

2 Infant level 2a. No infant-level exclusion criteria for data collection. We exclude infants from individual data and sample collection if their parents or legal guardians do not provide written informed consent. These infants contribute to cluster-aggregated outcomes.

Where it's running

  • Aglaia Kyriakou Children's Hospital
    Athens, Greece
    Recruiting
  • University General Hospital of Patras
    Pátrai, Greece
    Recruiting
  • Azienda Ospedaliera Universitaria S.Anna di Ferrara
    Ferrara, Italy
    Recruiting
  • Azienda Ospedaliera Universitaria di Modena
    Modena, Italy
    Recruiting
  • Ospedale Universitario Policlinico Paolo Giaccone
    Palermo, Italy
    Recruiting
  • Ospedale San Bortolo di Vicenza
    Vicenza, Italy
    Recruiting
Show 18 more locations
  • Hospital General Universitario Alicante
    Alicante, Spain
    Recruiting
  • Cruces University Hospital
    Bilbao, Spain
    Recruiting
  • Hospital Regional Universitario de Málaga (Carlos Haya)
    Málaga, Spain
    Recruiting
  • Birmingham Heartlands Hospital
    Birmingham, United Kingdom
    Recruiting
  • University Hospitals Coventry and Warwickshire
    Coventry, United Kingdom
    Recruiting
  • City St George's, University of London
    London, United Kingdom
    Recruiting
  • St Mary's Hospital
    Manchester, United Kingdom
    Recruiting
  • Norfolk and Norwich University Hospital NHS Foundation Trust
    Norwich, United Kingdom
    Recruiting
  • University General Hospital Attikon
    Attiki, Greece
    Completed
  • University Hospital of Heraklion
    Heraklion, Greece
    Completed
  • Ioannina University Hospital
    Ioannina, Greece
    Completed
  • Hippokration Hospital - Thessaloniki
    Thessaloniki, Greece
    Completed
  • Papageorgiou Hospital
    Thessaloniki, Greece
    Completed
  • University of Basel Children's Hospital
    Basel, Switzerland
    Completed
  • Inselspital - University Hospital of Bern
    Bern, Switzerland
    Completed
  • Hôpitaux Universitaires de Genève
    Geneva, Switzerland
    Completed
  • Children's Hospital of Eastern Switzerland St.Gallen
    Sankt Gallen, Switzerland
    Completed
  • Universitätsspital Zürich - University Hospital Zurich
    Zurich, Switzerland
    Completed

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.